| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.49 | 0.08 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.075 | 0.08 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |